Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Thaler

Showing results (21-30 of 292) with videos related to

Pageof 30
Sort By:
Blood|May 15, 1995
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorR Stauder, W Eisterer, J Thaler, et al.
Lancet (London, England)|December 24, 1994
Late-onset fatal neurological toxicity of fludarabineA Zabernigg, H Maier, J Thaler, et al.
British Journal of Haematology|December 1, 1989
Immunohistology for quantification of normal bone marrow lymphocyte subsetsJ Thaler, R Greil, O Dietze, et al.
Acta Haematologica|January 1, 1994
Contribution of DRC-1 and Leu-M5 to differential diagnosis in B cell lymphomasW Eisterer, W Hilbe, C Ludescher, et al.
Behring Institute Mitteilungen|December 1, 1985
[Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms]H Huber, C Gattringer, J Thaler, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1990
[Hematologic neoplasms: clinically latent--but needing treatment?]H Huber, B Fasching, J Drach, et al.
Leukemia Research|January 1, 1987
Progressive preleukemia presenting amegakaryocytic thrombocytopenic purpura: association of the 5q- syndrome with a decreased megakaryocytic colony formation and a defective production of Meg-CSFD Geissler, J Thaler, G Konwalinka, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
Information overload in healthcare: too much of a good thing?Irma Klerings, Alexandra S Weinhandl, Kylie J Thaler
Acta Haematologica|October 26, 1999
Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosisW Hilbe, T Berger, G Konwalinka, et al.
Leukemia & Lymphoma|January 1, 1994
Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation indexJ Thaler, F Fechner, M Herold, et al.
Pageof 30

Showing results (21-30 of 292) with videos related to

Sort By:
Pageof 30
Blood|May 15, 1995
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factorR Stauder, W Eisterer, J Thaler, et al.
Lancet (London, England)|December 24, 1994
Late-onset fatal neurological toxicity of fludarabineA Zabernigg, H Maier, J Thaler, et al.
British Journal of Haematology|December 1, 1989
Immunohistology for quantification of normal bone marrow lymphocyte subsetsJ Thaler, R Greil, O Dietze, et al.
Acta Haematologica|January 1, 1994
Contribution of DRC-1 and Leu-M5 to differential diagnosis in B cell lymphomasW Eisterer, W Hilbe, C Ludescher, et al.
Behring Institute Mitteilungen|December 1, 1985
[Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms]H Huber, C Gattringer, J Thaler, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1990
[Hematologic neoplasms: clinically latent--but needing treatment?]H Huber, B Fasching, J Drach, et al.
Leukemia Research|January 1, 1987
Progressive preleukemia presenting amegakaryocytic thrombocytopenic purpura: association of the 5q- syndrome with a decreased megakaryocytic colony formation and a defective production of Meg-CSFD Geissler, J Thaler, G Konwalinka, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 11, 2015
Information overload in healthcare: too much of a good thing?Irma Klerings, Alexandra S Weinhandl, Kylie J Thaler
Acta Haematologica|October 26, 1999
Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosisW Hilbe, T Berger, G Konwalinka, et al.
Leukemia & Lymphoma|January 1, 1994
Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation indexJ Thaler, F Fechner, M Herold, et al.
Pageof 30